Latest Nitroxyl Stories
- Results from two studies presented at American Heart Association Scientific Sessions 2014 - CHAPEL HILL, N.C., Nov.
-- Next-generation HNO prodrug targeting severe heart failure was well tolerated and showed hemodynamic activity in a Phase I clinical trial -- CHAPEL HILL, N.C., July 28, 2014 /PRNewswire/
The Company Specializes in Selling an All-Natural Nitric Oxide Boosting Supplement Called Nitroxyl LOS ANGELES, July 21, 2014 /PRNewswire-iReach/ -- Nitrosolution.com, a website that
Cardioxyl now evaluating clinical safety and tolerability of improved second-generation HNO prodrug targeting acute decompensated heart failure CHAPEL HILL, N.C., Feb.
Microbiologists identified the structure of the bacterial enzyme that decomposes nitrous oxide and the decomposition mechanism.
- Growing in low tufty patches.